Press Release

Jan, 04 2024

Allergy Insights: Understanding, Managing, and Navigating the Complex World of Allergic Reactions and Sensitivities

The Russia allergy market represents a dynamic landscape centered around the diagnosis, treatment, and management of allergic conditions within the country. With a diverse range of environmental factors contributing to allergies, the market encompasses pharmaceuticals, diagnostics, and therapeutic interventions. Healthcare providers and pharmaceutical companies play pivotal roles in addressing the prevalence of allergies, ranging from respiratory to food-related sensitivities. Diagnostic tools, such as allergy testing kits and specialized clinics, contribute significantly to the market's growth.

Access Full Report @

Data Bridge Market Research analyses that the Russia Allergy Market which was USD 387.3 million in 2022, is expected to reach USD 706.3 million by 2030, at a CAGR of 7.8% during the forecast period 2023 to 2030. Continuous advancements in allergy diagnostic technologies improve precision and accessibility, facilitating early detection and personalized treatment plans, thereby elevating the overall standard of allergy care and patient outcomes.

Key Findings of the Study

Russia Allergy Market

Rising patient demand for allergy relief is expected to drive the market's growth rate

Surging patient demand for allergy relief fuels a need for over-the-counter and prescription medications, driving market expansion. The increasing desire for effective solutions underscores a growing awareness of allergies, pushing individuals to seek diverse treatment options. This trend amplifies the market's scope and emphasizes the pivotal role medications play in meeting the rising expectations of those seeking efficient and accessible means of allergy management.

Report Scope and Market Segmentation

Report Metric


Forecast Period

2023 to 2030

Base Year


Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Antihistamines, Corticosteroids, Decongestants, Monoclonal Antibody, Mast Cell Stabilizers, Immunotherapy, and Others), Allergen Type (Airborne Allergens, Food Allergens, Insect Stings/ Bites, Drug Allergens, Metal/ Chemical Allergens, Animal Saliva and Others), Disease Areas (Allergic Rhinitis, Atopic Dermatitis, Conjunctivitis, Urticaria, Asthma, Anaphylaxis, Venom Allergy, and Others), Dosage Form (Liquid, Solid, Semi-Solid), Route of Administration (Nasal, Oral, Parenteral, Topical, and Others), Mode of Purchase (Prescription and Over the Counter), End User (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Market Players Covered

Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Lupin (India), RusBioPharm (India), Santen Pharmaceutical Co., Ltd. (Japan), Viatris Inc. (U.K.), Sun Pharmaceutical Industries Ltd (India)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The Russia allergy market is segmented on the basis of product, allergen type, disease areas, dosage form, route of administration, mode of purchase, end user, and distribution channel. 

  • On the basis of product, the Russia allergy market is segmented into antihistamines, corticosteroids, decongestants, monoclonal antibody, mast cell stabilizers, immunotherapy, and others
  • On the basis of allergen type, the Russia allergy market is segmented into airborne allergens, food allergens, insect stings/ bites, drug allergens, metal/ chemical allergens, animal saliva, and others
  • On the basis of disease areas, the Russia allergy market is segmented into allergic rhinitis, atopic dermatitis, conjunctivitis, urticaria, asthma, anaphylaxis, venom allergy, and others
  • On the basis of dosage form, the Russia allergy market is segmented into liquid, solid, and semi-solid
  • On the basis of route of administration, the Russia allergy market is segmented into nasal, oral, parenteral, topical, and others
  • On the basis of mode of purchase, the Russia allergy market is segmented into prescription and over the counter
  • On the basis of end user, the Russia allergy market is segmented into hospitals, homecare, specialty clinics, and others
  • On the basis of distribution channel, the Russia allergy market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy

Major Players

Data Bridge Market Research recognizes the following companies as the major Russia allergy market players in Russia allergy market are Merck & Co., Inc. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Lupin (India), RusBioPharm (India), Santen Pharmaceutical Co., Ltd. (Japan), Viatris Inc. (U.K.), Sun Pharmaceutical Industries Ltd (India)

Russia Allergy Market

Market Developments

  • In August 2022, Glenmark Pharmaceuticals launched a new treatment for seasonal allergies in the United States. It's a special combination therapy, the only one approved, designed to relieve symptoms such as sneezing and runny nose. This offers a more convenient and effective option for people dealing with seasonal allergic rhinitis, making it easier to manage and alleviate their allergy-related discomfort
  • In August 2022, STAT Medical launched user-friendly at-home allergy test kits. These kits make it easy for individuals to check for common food and respiratory allergies using a simple finger prick. This innovative product empowers people to self-screen conveniently, providing a practical and accessible way to identify potential allergies in the comfort of their homes
  • In June 2022, Oncologica, a renowned healthcare testing lab in Cambridge, introduced the Allergyfocus test. This test helps people find out which common allergens around the world trigger reactions in their bodies. It's a practical way for individuals dealing with allergies to identify specific culprits and take informed steps towards managing their condition, enhancing overall well-being
  • In March 2022, Perrigo got approval from the US FDA for over-the-counter use of Nasonex 24HR Allergy (mometasone furoate monohydrate 50mcg). This means people can now buy Nasonex without a prescription for relief from allergies, as the FDA found it safe and effective for non-prescription use. Perrigo's achievement expands access to allergy relief, providing more options for those seeking effective over-the-counter solutions

For more detailed information about the Russia allergy market report, click here –

Client Testimonials